THE International Pharmaceutical Federation has stressed the importance of pharmaceutical science in developing national responses to dementia, in a presentation to the World Health Organization (WHO) board.
As well as dementia research and innovation, "successful existing strategies show that pharmacists are well placed to be the co-organisers of awareness campaigns, screening activities and of community-based dementia partnership programs," FIP said.
The Federation said it's keen to mobilise the wide range of technical expertise among pharmacists worldwide in order to finalise a global action plan to tackle dementia.
FIP also spoke to the WHO Executive Board about antimicrobial resistance, medicines shortages, human resources for health, the Global Vaccine Action Plan, cancer prevention and control and how countries are working against counterfeit medicines.
A series of statements on these issues can now be viewed online at www.fip.org.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Feb 17